OR WAIT null SECS
November 26, 2012
Novartis announced that it has received FDA approval for a seasonal influenza vaccine produced in cell culture, the first seasonal vaccine produced by this method to be approved in the US.
June 20, 2012
PharmTech's monthly newsletter, Equipment and Processing Report, reviews the Editor's Picks for the June 2012 edition from EMD Millipore and Meissner Filtration Products.
June 02, 2012
Extensive physicochemical characterization of the innovator product and the proposed biosimilar provides the foundation for demonstrating biosimilarity.
May 01, 2012
In this technical forum, experts describe different methods of rapid microbial testing and their applications.
March 15, 2012
On Mar. 7, 2012, GE Healthcare announced an agreement to acquire Xcellerex, a supplier of manufacturing technologies for the biopharmaceutical industry, for an undisclosed amount.
June 02, 2011
More sophisticated biological expression systems expand the functionality of the traditional systems for protein synthesis.
October 02, 2010
Drugmakers hatch new manufacturing paradigms in the wake of the 2009 H1N1 influenza pandemic.
September 01, 2008
The authors describe the critical aspects of an ideal fermentation services provider.
June 02, 2008
Creating a kinder, gentler manufacturing process that doesn't kill the product is the goal of process developers doing large-scale cell culture for cell therapy.